Tus kws kho mob
QP33-21 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) Criteria: Winlevi®
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 28, 2021
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2251 - 2260 ntawm 3685
Tus kws kho mob
Upcoming-policies-effective-May-31-2021.pdf
Tus kws kho mob
QP37-21 New Clinical Survey for Psychological and Neuropsychological Testing
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 28, 2021
Tus kws kho mob
P5R2-21 New Reimbursement Policy: Outpatient Services Prior to an Inpatient Admission
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P18-21 New Reimbursement Policy for Minnesota Health Care Programs Modifier 90: Reference (Outside) Laboratory and Pass-Through Billing
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P11R1-21 UPDATE: Updated Preadmission Services for Inpatient Stays Reimbursement Policy for Minnesota Health Care Programs Members
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2021
Tus kws kho mob
2021 April Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P17-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P15-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates — Effective May 31, 2021
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2021